The company has been a pioneer in research and development, becoming the first in the industry to establish a post-doctoral research program and publishing more than 60 scientific papers at CORESTA, the premier international tobacco forum.

With a state-level enterprise technical center, the company holds over 2,000 patents, of which more than 1,500 are authorized. Its comprehensive innovation capabillity ranks among the top three in China's tobacco industry.

A commitment to quality drives its operations, underscored by the establishment of a comprehensive quality management system that spans from tobacco cultivation to market sales. By focusing on melticulous quality contorl at the source, the organization oversees 65,000 hectares of tobacco plantations in China, ensuring consistent excellence and reliablility in its products.

Maintaining a stable supply of premium tobacco leaves has been a cornorstone of its operations. Since 2005, it has partnered with Philip Morris to produce Malboro cigarettes and authorised the production of Harmony cigarettes, extending their distribution across Asia, Oceania, and South America. These efforts have further strengthening its global standing.

The company operates two key industrial laboratories focused on digital flavor research and functional cigarette materials. Its state-of-art technologies, including tar reduction and harm minimization techniques, along with advancements in genetic breeding, place its research capabilities on par with global leaders.